[go: up one dir, main page]

BE898057A - TREATMENT OF ANDROID CALVITIS. - Google Patents

TREATMENT OF ANDROID CALVITIS.

Info

Publication number
BE898057A
BE898057A BE0/211754A BE211754A BE898057A BE 898057 A BE898057 A BE 898057A BE 0/211754 A BE0/211754 A BE 0/211754A BE 211754 A BE211754 A BE 211754A BE 898057 A BE898057 A BE 898057A
Authority
BE
Belgium
Prior art keywords
calvitis
android
treatment
lower limit
normal range
Prior art date
Application number
BE0/211754A
Other languages
French (fr)
Original Assignee
Mortimer Christopher H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mortimer Christopher H filed Critical Mortimer Christopher H
Publication of BE898057A publication Critical patent/BE898057A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

L'invention concerne un procédé pour réduire la perte des cheveux chez l'homme, caractérisé en ce que l'on administre à un homme, une composition pharmaceutique comprenant un ingrédient actif qui, par son administration, provoque un abaissement des taux en dihydrotestostérone du plasma jusqu'à une valeur sensiblement en-dessous de la limite inférieure de la plage normale, tout en n'abaissant pas le taux en testostérone du plasma en-dessous de la limite inférieure de la plage normale dans une mesure telle qu'elle provoquerait un disfonctionnement sexuel.The invention relates to a method for reducing hair loss in humans, characterized in that a pharmaceutical composition comprising an active ingredient which, by its administration, causes a reduction in the dihydrotestosterone levels of plasma to a value substantially below the lower limit of the normal range, while not lowering the plasma testosterone level below the lower limit of the normal range to such an extent that it would cause sexual dysfunction.

BE0/211754A 1982-10-21 1983-10-21 TREATMENT OF ANDROID CALVITIS. BE898057A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43579882A 1982-10-21 1982-10-21

Publications (1)

Publication Number Publication Date
BE898057A true BE898057A (en) 1984-02-15

Family

ID=23729847

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/211754A BE898057A (en) 1982-10-21 1983-10-21 TREATMENT OF ANDROID CALVITIS.

Country Status (3)

Country Link
BE (1) BE898057A (en)
DE (1) DE3338339A1 (en)
ZA (1) ZA837859B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046279A3 (en) * 1998-03-11 2001-02-22 Endorech Inc INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) * 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
EP0240630A3 (en) * 1986-04-10 1989-01-25 University Of Miami Treatment of skin of over androgenicity using compositions containing pregnenolone
DE3738620A1 (en) * 1987-11-13 1989-05-24 Luderschmidt Christoph USE OF ETHISTERONE FOR TOPICAL TREATMENT OF ACNE OR ANDROGENETIC ALOPECIA
DE4100975A1 (en) * 1991-01-15 1992-07-16 Weuffen Wolfgang Cosmetic or pharmaceutical preparations for improving hair quality and promoting hair growth
DE4214953C2 (en) * 1992-05-06 1995-05-18 Arrowdean Ltd Medicines to increase testosterone levels

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046279A3 (en) * 1998-03-11 2001-02-22 Endorech Inc INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE
US6541463B1 (en) 1998-03-11 2003-04-01 Endorecherche, Inc. Inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase and methods for their use

Also Published As

Publication number Publication date
ZA837859B (en) 1984-11-28
DE3338339A1 (en) 1984-04-26

Similar Documents

Publication Publication Date Title
ES2160631T3 (en) RETINOID COMPOSITIONS FOR TOPICAL APPLICATION.
ATE220896T1 (en) CONTROLLED RELEASE HYDROGEL FORMULATION
TNSN95061A1 (en) OXALYLAMINO-BENZOFURAN AND BENZOTHIENYL DERIVATIVES
AR055050A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING N-ETIL-9A, 11A, 15S- TRIHIDOXI-17-FENIL-18,19,20-TRINOR-PROSTA -5Z, 13E- DIEN-1-AMIDA (BIMATOPROST) AND BENZALCONIUM CHLORIDE, AND USE OF THESE COMPOUNDS FOR THE PREPARATION OF THE SAME
MX9300690A (en) SHAMPOO COMPOSITIONS AND SUSPENSION AGENT OF THE SAME.
WO1998005323A3 (en) Method of regulating the female reproductive system through angiogenesis inhibitors
RU93058524A (en) SYSTEMS WITH REGULATED RELEASE AND LOW DOSES OF ANDROGENS, METHOD FOR PRODUCING THEM AND METHOD OF TREATMENT USING THESE SYSTEMS
AU5348194A (en) Method of preventing nmda receptor complex-mediated neuronal damage
IL138476A0 (en) Method for treating pharmaceutical compositions by special use of anti-oxidant
TNSN99132A1 (en) A COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF OSTEOPOROSIS OR ALTERATIONS DUE TO MENOPAUSE SYNDROME
EP0405930A3 (en) Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives
MX9702349A (en) Use of 9-deoxy prostaglandin derivatives to treat glaucoma.
UY25067A1 (en) SERTRALINE ACETATE, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, AND PREPARATION PROCEDURES.
DE69311361D1 (en) COMPOSITIONS FOR TREATING GLAUCOMA CONTAINING PROSTAGLANDINES AND CLONIDINE DERIVATIVES
EA200001125A1 (en) PHARMACEUTICAL PHARMACEUTICAL COMPOSITIONS
MXPA02000437A (en) Composition for treatment of external secretion disorders.
CA2324904A1 (en) Topical hormonal composition with systemic effect
BE898057A (en) TREATMENT OF ANDROID CALVITIS.
BE900564A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES.
ES2128051T3 (en) DOUBLE LINK ISOMER OF EQUILINE, FROM ACID ISOMERIZATION OF EQUILINE.
DE59309877D1 (en) Gel, especially for ophthalmology
FR2397682A1 (en) METHOD AND DEVICE FOR THE CONSTRUCTION OF AN IMAGE BY TOMOGRAPHY
DK0719276T3 (en) Estradiol esters with strong oral action as well as pharmaceutical preparations containing them
FR2674437B1 (en) PHARMACEUTICAL COMPOSITION, ESPECIALLY USEFUL IN THE TREATMENT OF GASTRO-ÓOESOPHAGIAN CONDITIONS.
AU2002211577A1 (en) Protecting therapeutic compositions from host-mediated inactivation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MORTIMER CHRISTOPHER H.

Effective date: 19891031